BTIG initiated coverage on Abbott Labs (NYSE: ABT) with a Buy rating and a price target of $56. Analyst Dane ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE